1. Home
  2. GRFS vs CFLT Comparison

GRFS vs CFLT Comparison

Compare GRFS & CFLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • CFLT
  • Stock Information
  • Founded
  • GRFS 1940
  • CFLT 2014
  • Country
  • GRFS Spain
  • CFLT United States
  • Employees
  • GRFS N/A
  • CFLT N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • CFLT EDP Services
  • Sector
  • GRFS Health Care
  • CFLT Technology
  • Exchange
  • GRFS Nasdaq
  • CFLT Nasdaq
  • Market Cap
  • GRFS 6.6B
  • CFLT 6.9B
  • IPO Year
  • GRFS 2006
  • CFLT 2021
  • Fundamental
  • Price
  • GRFS $9.61
  • CFLT $20.95
  • Analyst Decision
  • GRFS Hold
  • CFLT Buy
  • Analyst Count
  • GRFS 1
  • CFLT 31
  • Target Price
  • GRFS $10.30
  • CFLT $28.97
  • AVG Volume (30 Days)
  • GRFS 550.4K
  • CFLT 6.0M
  • Earning Date
  • GRFS 01-01-0001
  • CFLT 10-27-2025
  • Dividend Yield
  • GRFS 1.47%
  • CFLT N/A
  • EPS Growth
  • GRFS 132.60
  • CFLT N/A
  • EPS
  • GRFS 0.53
  • CFLT N/A
  • Revenue
  • GRFS $8,744,226,659.00
  • CFLT $1,064,824,000.00
  • Revenue This Year
  • GRFS $5.61
  • CFLT $21.83
  • Revenue Next Year
  • GRFS $6.70
  • CFLT $16.44
  • P/E Ratio
  • GRFS $24.41
  • CFLT N/A
  • Revenue Growth
  • GRFS 9.32
  • CFLT 23.02
  • 52 Week Low
  • GRFS $6.19
  • CFLT $15.64
  • 52 Week High
  • GRFS $11.14
  • CFLT $37.90
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 41.63
  • CFLT 60.20
  • Support Level
  • GRFS $9.56
  • CFLT $19.28
  • Resistance Level
  • GRFS $10.23
  • CFLT $21.49
  • Average True Range (ATR)
  • GRFS 0.18
  • CFLT 0.84
  • MACD
  • GRFS -0.01
  • CFLT 0.15
  • Stochastic Oscillator
  • GRFS 11.85
  • CFLT 83.16

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About CFLT Confluent Inc.

Confluent Inc provides a data streaming platform that enables customers to connect their applications, systems, and data layers and can be deployed as a fully managed cloud-native software-as-a-service (SaaS) offering. Its products include Confluent Cloud, a self-managed software offering, Confluent Platform, a managed service offering where the raw data resides inside a customer's cloud environment, and WarpStream, among others. Confluent also offers professional services and education services. The company generates revenue from the sale of subscriptions and services. Geographically, it generates a majority of its revenue from its business in the United States and the rest from International markets.

Share on Social Networks: